Aurora sponsors cancer-pain study featuring MedReleaf capsules. Continue reading Aurora Cannabis sponsors cancer-pain study directed by internationally acclaimed oncologist.
Approximately 60 patients suffering breakthrough cancer pain to participate in clinical trial that compares fentanyl with inhaled medical cannabis. Continue reading UPDATED: Cannabis vs. fentanyl for cancer pain; clinical trial
Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.
A University of Utah clinical trial is evaluating the effectiveness two different combinations of THC and CBD as treatment for chronic pain and life functioning. Continue reading Clinical trial: THC and CBD for chronic pain
Cannabis extracts control pain, reduce muscle paralysis and stiffness, and even protect the brain from further injury in MS patients, according to a new study out of Rome. Continue reading Mounting evidence that cannabis is good medicine for MS
An international research project led by McGill University will examine the potential of CanniMed CBD oil to treat chronic pain, and related anxiety and depression. Continue reading Aurora supporting study of CBD as treatment for pain, depression, anxiety
Studies out of Isreal, Italy, Spain, China, Germany and other European countries say that genetic deficiencies of the endocannabinoid system may be at play in severe headaches. Continue reading Cannabis for migraines
Clues to the anti-headache mechanisms of cannabis can be found by looking at headache conditions that are relieved by reducing intracranial pressure. Dexanabinol, a synthetic cannabinoid, has been found to relieve intracranial pressure and improve outcomes after traumatic brain injury. In addition, a double-blind, placebo-controlled trial of 26 patients found that a synthetic form of THC (Nabilone) was “significantly more effective” than Ibuprofen in reducing pain intensity. It was also suggested that the anti-vomiting properties seen in the treatment of nausea brought on by chemotherapy might also be effective in treating migraine. Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication … Continue reading Man-made THC improves headache in clinical trials
more targeted treatments may help alleviate pain without dangerous side effects such as addiction.
Continue reading Targeting pain